11/11/2007

USANA Ranks Among the Top in the Comparative Guide To Nutritional Supplements

USANA CELEBRATES ANOTHER RECORD YEAR



USANA flagship Essentials and HealthPak 100 nutritional supplements rate 'best of the best' out of 1,600 products evaluated in Canada and United States.

USANA Health Sciences, a leading global health supplement manufacturer, once again received 5-Star Gold Standard ratings for its nutritional products in the much-anticipated 4th and latest edition of the NutriSearch Comparative Guide to Nutritional Supplements.™


Author Lyle MacWilliam MSc, FP, a former biochemist and educator, released the 1st edition of the guide in 1999 to help consumers make informed, scientifically based decisions about nutritional supplements. The latest edition features detailed comparisons of more than 1,600 products based on a blended standard created from published recommendations of 12 nutritional authorities and 18 rating criteria developed from scientific literature.


USANA's Essentials and HealthPak 100™ products both received 5-Star Gold Standard ratings and the NutriSearch Gold Medal of Achievement™. USANA is no stranger to this recognition as similar high ratings were given in the first, second and third editions of the guide.


According to the comparative guide, companies that receive 5-Star Gold Ratings must meet the "highest standards of quality in research, formulations and manufacturing." The guide also noted that companies awarded the NutriSearch Gold Medal of Achievement™ have gone to considerable expense to meet and exceed the most stringent of manufacturing standards. USANA was one of only four companies rated this highly and asked by publishers to include a company description within the latest edition of the guide.


"It is gratifying to have our Essentials and HealthPak products independently recognized for excellence," explains Dr. Tim Wood, USANA's executive vice president of research and development. "We applaud Mr. MacWilliam's efforts to raise the bar on quality within the supplement industry."

No comments: